| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
47,926 |
45,906 |
$7.79M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
54,811 |
51,202 |
$7.33M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
25,529 |
24,293 |
$5.78M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12,219 |
11,750 |
$1.65M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
5,242 |
4,530 |
$1.36M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,766 |
3,643 |
$1.30M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
4,415 |
3,941 |
$1.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,571 |
4,329 |
$775K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,900 |
6,578 |
$661K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,337 |
9,771 |
$626K |
| 87631 |
|
4,423 |
4,304 |
$623K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13,193 |
11,076 |
$597K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,849 |
4,372 |
$595K |
| 80053 |
Comprehensive metabolic panel |
31,802 |
29,203 |
$418K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,714 |
2,613 |
$415K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,232 |
7,479 |
$413K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,179 |
6,355 |
$384K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,456 |
2,936 |
$378K |
| 71046 |
Radiologic examination, chest; 2 views |
6,826 |
6,564 |
$376K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,959 |
8,343 |
$363K |
| G0378 |
Hospital observation service, per hour |
774 |
711 |
$350K |
| 73562 |
|
3,873 |
3,411 |
$341K |
| A0425 |
Ground mileage, per statute mile |
5,198 |
4,078 |
$325K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,026 |
2,532 |
$294K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,938 |
29,765 |
$269K |
| 71045 |
Radiologic examination, chest; single view |
4,700 |
4,351 |
$241K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,754 |
7,524 |
$218K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
955 |
929 |
$202K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
589 |
575 |
$195K |
| 73610 |
|
1,805 |
1,665 |
$174K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
814 |
802 |
$168K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,470 |
4,374 |
$167K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,357 |
4,057 |
$161K |
| 73030 |
|
2,129 |
1,939 |
$161K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,465 |
4,372 |
$160K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,767 |
7,613 |
$124K |
| 81513 |
|
938 |
915 |
$123K |
| 73630 |
|
1,967 |
1,793 |
$120K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,594 |
6,419 |
$119K |
| 73110 |
|
1,587 |
1,370 |
$116K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
752 |
698 |
$105K |
| 84484 |
|
6,646 |
5,439 |
$91K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,494 |
1,622 |
$90K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
610 |
609 |
$90K |
| 73130 |
|
1,238 |
1,100 |
$89K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,396 |
8,820 |
$85K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
254 |
248 |
$84K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,056 |
3,024 |
$80K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,761 |
1,694 |
$78K |
| 81025 |
|
6,676 |
6,340 |
$76K |
| 36415 |
Collection of venous blood by venipuncture |
19,826 |
18,546 |
$73K |
| 96376 |
|
2,383 |
1,731 |
$72K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,977 |
5,690 |
$71K |
| 83690 |
|
8,597 |
7,978 |
$71K |
| 81001 |
|
12,867 |
12,094 |
$67K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,605 |
7,519 |
$63K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
656 |
643 |
$63K |
| 72100 |
|
779 |
769 |
$62K |
| A0998 |
Ambulance response and treatment, no transport |
829 |
810 |
$62K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
677 |
665 |
$61K |
| 97161 |
|
1,707 |
1,664 |
$61K |
| 94726 |
|
666 |
653 |
$60K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,268 |
4,616 |
$60K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
818 |
795 |
$58K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
814 |
602 |
$56K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
822 |
790 |
$55K |
| 82962 |
|
7,051 |
5,605 |
$51K |
| 94060 |
|
446 |
437 |
$50K |
| 87081 |
|
5,854 |
5,699 |
$50K |
| 87650 |
|
2,133 |
2,098 |
$49K |
| 83735 |
|
6,803 |
6,246 |
$48K |
| 94664 |
|
705 |
691 |
$44K |
| 73502 |
|
946 |
908 |
$42K |
| 84439 |
|
4,600 |
4,535 |
$40K |
| 76830 |
Ultrasound, transvaginal |
447 |
444 |
$39K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
139 |
137 |
$39K |
| 95811 |
|
67 |
66 |
$39K |
| 87040 |
|
2,810 |
1,923 |
$38K |
| 83605 |
|
4,348 |
3,795 |
$36K |
| 10060 |
|
435 |
410 |
$36K |
| 83880 |
|
1,757 |
1,655 |
$35K |
| 94375 |
|
350 |
341 |
$35K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,360 |
1,348 |
$34K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
959 |
937 |
$33K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
873 |
849 |
$33K |
| 85027 |
|
5,123 |
4,764 |
$33K |
| J3490 |
Unclassified drugs |
19,541 |
8,306 |
$33K |
| 94729 |
|
684 |
673 |
$32K |
| 82077 |
|
2,650 |
2,409 |
$30K |
| 87481 |
|
936 |
914 |
$29K |
| 85379 |
|
1,612 |
1,580 |
$28K |
| 81514 |
|
116 |
115 |
$28K |
| 84702 |
|
1,523 |
1,245 |
$28K |
| 87077 |
|
3,087 |
2,930 |
$28K |
| 84703 |
|
2,114 |
2,032 |
$27K |
| 87186 |
|
2,241 |
2,148 |
$27K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
304 |
303 |
$26K |
| 86780 |
|
1,905 |
1,885 |
$26K |
| 71250 |
|
225 |
222 |
$26K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
79 |
78 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,104 |
1,074 |
$24K |
| 80061 |
Lipid panel |
1,976 |
1,960 |
$24K |
| 73080 |
|
352 |
310 |
$24K |
| 81003 |
|
5,524 |
5,297 |
$23K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
41 |
40 |
$22K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
233 |
233 |
$22K |
| 85610 |
|
5,128 |
4,621 |
$22K |
| 86850 |
|
2,142 |
2,055 |
$21K |
| 82728 |
|
1,495 |
1,486 |
$21K |
| 59025 |
Fetal non-stress test |
144 |
123 |
$20K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
720 |
714 |
$19K |
| 71101 |
|
233 |
231 |
$19K |
| 93971 |
|
269 |
259 |
$18K |
| 82805 |
|
348 |
312 |
$18K |
| 86803 |
|
1,227 |
1,221 |
$17K |
| 73120 |
|
163 |
133 |
$16K |
| 93976 |
|
144 |
135 |
$15K |
| 90715 |
|
988 |
972 |
$13K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,674 |
1,270 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
979 |
947 |
$13K |
| 87660 |
|
587 |
570 |
$13K |
| 87480 |
|
573 |
557 |
$13K |
| 87510 |
|
572 |
556 |
$13K |
| 97162 |
|
324 |
318 |
$13K |
| 86900 |
|
2,302 |
2,193 |
$12K |
| 82075 |
|
387 |
346 |
$12K |
| 96367 |
|
218 |
187 |
$12K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
31 |
30 |
$12K |
| 87653 |
|
289 |
288 |
$11K |
| 73090 |
|
159 |
144 |
$11K |
| 74019 |
|
114 |
108 |
$10K |
| 86901 |
|
2,300 |
2,192 |
$10K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
331 |
331 |
$10K |
| 76801 |
|
114 |
105 |
$10K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
27 |
27 |
$10K |
| 73140 |
|
163 |
149 |
$10K |
| 94618 |
|
133 |
129 |
$10K |
| 29125 |
|
89 |
89 |
$9K |
| 82607 |
|
682 |
675 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
263 |
250 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
151 |
131 |
$9K |
| 86140 |
|
2,176 |
2,067 |
$8K |
| 20610 |
|
117 |
99 |
$8K |
| 83550 |
|
930 |
919 |
$8K |
| 87430 |
|
483 |
479 |
$8K |
| 82140 |
|
555 |
512 |
$8K |
| 82570 |
|
1,639 |
1,601 |
$8K |
| 12001 |
|
83 |
83 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,818 |
3,375 |
$8K |
| 36000 |
|
1,198 |
1,167 |
$8K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
38 |
37 |
$7K |
| 73590 |
|
125 |
111 |
$7K |
| 80305 |
|
525 |
422 |
$7K |
| 82043 |
|
1,286 |
1,278 |
$7K |
| 83540 |
|
994 |
982 |
$7K |
| 80076 |
|
612 |
595 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,949 |
3,150 |
$6K |
| 82746 |
|
472 |
468 |
$6K |
| 85652 |
|
1,307 |
1,253 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
1,608 |
1,182 |
$6K |
| 87340 |
|
535 |
531 |
$6K |
| 12002 |
|
70 |
66 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,954 |
4,503 |
$5K |
| 83655 |
|
367 |
366 |
$5K |
| 72040 |
|
74 |
73 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$5K |
| 97750 |
|
175 |
171 |
$5K |
| 87807 |
|
320 |
308 |
$5K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
32 |
32 |
$5K |
| 86762 |
|
338 |
337 |
$5K |
| 72110 |
|
66 |
66 |
$5K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
209 |
149 |
$5K |
| 70498 |
|
12 |
12 |
$4K |
| 70486 |
|
28 |
27 |
$4K |
| 87070 |
|
319 |
300 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
43 |
42 |
$4K |
| 51702 |
|
53 |
50 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,320 |
3,844 |
$3K |
| 70496 |
|
12 |
12 |
$3K |
| 80143 |
|
223 |
203 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,221 |
1,658 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
766 |
716 |
$3K |
| 74018 |
|
57 |
50 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
117 |
117 |
$3K |
| 94760 |
|
429 |
297 |
$3K |
| 80179 |
|
192 |
175 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
27 |
27 |
$3K |
| 80074 |
|
52 |
49 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,224 |
1,955 |
$3K |
| 82550 |
|
329 |
293 |
$2K |
| 85014 |
|
834 |
815 |
$2K |
| 85018 |
|
800 |
781 |
$2K |
| 85730 |
|
358 |
346 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,474 |
1,425 |
$2K |
| 76770 |
|
30 |
27 |
$2K |
| 87205 |
|
320 |
300 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
16 |
16 |
$2K |
| 73522 |
|
12 |
12 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
329 |
280 |
$1K |
| 93970 |
|
13 |
13 |
$1K |
| 87210 |
|
184 |
181 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,028 |
935 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
81 |
58 |
$986.97 |
| 73560 |
|
16 |
12 |
$953.73 |
| 36416 |
|
539 |
522 |
$925.62 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
551 |
496 |
$907.16 |
| 83525 |
|
72 |
71 |
$896.86 |
| J2060 |
Injection, lorazepam, 2 mg |
599 |
512 |
$865.78 |
| 86038 |
|
70 |
68 |
$773.98 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
747 |
700 |
$674.61 |
| J1790 |
Injection, droperidol, up to 5 mg |
216 |
200 |
$648.13 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
21 |
14 |
$643.12 |
| 84481 |
|
27 |
27 |
$533.98 |
| 73552 |
|
14 |
14 |
$529.26 |
| 81002 |
|
148 |
142 |
$521.90 |
| 86787 |
|
38 |
38 |
$497.01 |
| 87075 |
|
38 |
38 |
$476.07 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
56 |
55 |
$455.10 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
815 |
684 |
$446.21 |
| 87581 |
|
12 |
12 |
$435.48 |
| 87486 |
|
12 |
12 |
$435.48 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
236 |
236 |
$434.28 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
76 |
74 |
$432.44 |
| 94761 |
|
27 |
26 |
$428.32 |
| 82010 |
|
55 |
50 |
$377.37 |
| 82950 |
|
68 |
66 |
$342.37 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
16 |
12 |
$314.58 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
51 |
49 |
$312.47 |
| 82248 |
|
60 |
42 |
$287.59 |
| J3360 |
Injection, diazepam, up to 5 mg |
32 |
32 |
$269.18 |
| 86431 |
|
41 |
41 |
$246.90 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
128 |
83 |
$219.37 |
| 82247 |
|
42 |
26 |
$203.40 |
| 90670 |
|
58 |
58 |
$198.43 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
12 |
12 |
$174.00 |
| G0008 |
Administration of influenza virus vaccine |
115 |
115 |
$145.51 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
193 |
167 |
$143.46 |
| 90686 |
|
24 |
24 |
$126.82 |
| J3411 |
Injection, thiamine hcl, 100 mg |
35 |
30 |
$125.26 |
| S0028 |
Injection, famotidine, 20 mg |
65 |
58 |
$119.39 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
13 |
$95.79 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
188 |
175 |
$89.48 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
31 |
24 |
$67.17 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
51 |
39 |
$39.97 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
16 |
15 |
$31.86 |
| J1630 |
Injection, haloperidol, up to 5 mg |
13 |
13 |
$28.18 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
13 |
$21.64 |
| J3480 |
Injection, potassium chloride, per 2 meq |
16 |
12 |
$18.04 |
| J1815 |
Injection, insulin, per 5 units |
56 |
25 |
$17.65 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
15 |
12 |
$15.00 |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
67 |
67 |
$14.39 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
15 |
12 |
$2.72 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
139 |
127 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
199 |
181 |
$0.00 |